Privia Health Screening Program Increases Colorectal Cancer Screening Rates

Amalgam Rx

WILMINGTON, DE — A colorectal cancer screening program led by Privia Health (Nasdaq: PRVA) increased screening rates to 84 percent in 2024, according to a case study supported by Amalgam Rx Inc. and Exact Sciences Corp. (Nasdaq: EXAS).

The program used electronic health record–integrated workflows and automated patient outreach to identify and engage patients eligible for colorectal cancer screening.

Privia Health said the screening rate exceeded national benchmarks and the National Colorectal Cancer Roundtable’s goal of 80 percent.

The program launched in 2023 and expanded nationally in 2024, combining Amalgam Rx clinical decision support tools with Exact Sciences’ Cologuard test as a noninvasive screening option for eligible patients aged 45 and older.

READ:  Apache Software Foundation Promotes Gluten, Polaris to Top-Level Projects

More than 42,000 patients were engaged through automated outreach across two initial markets, according to the case study.

The program later expanded nationally to reach more than 100,000 patients.

Approximately 23,000 colorectal cancer screening orders were processed within a 48-hour period, the organizations said.

The screening effort identified more than 550 patients who required diagnostic follow-up, based on a positivity rate of about 10 percent at the time of analysis.

The case study also found that 37 percent of patients contacted through the outreach campaign scheduled physician appointments.

“In value-based care, the goal is proactive prevention, but that often comes with a heavy administrative burden,” said Ryan Graham, vice president of practice operations and value-based care at Privia Health.

READ:  Acorn Energy Reports Higher 2025 Revenue on Monitoring Growth

Graham said the program used technology to identify patients needing screening while reducing administrative work for healthcare providers.

The program integrates patient outreach, screening orders and documentation within the athenaClinicals electronic health record system, according to the organizations.

Ryan Sysko, chief executive officer of Amalgam Rx, said the collaboration combined clinical decision support and patient engagement tools within existing clinical workflows.

Privia Health said it is evaluating how similar approaches could be applied to other preventive care initiatives.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.